Fny Investment Advisers, LLC Gilead Sciences, Inc. Transaction History

Fny Investment Advisers, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $7,327 - $8,309	100 New	100 $8,000
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $2,020 - $2,275	-35 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $2,027 - $2,540	35 New	35 $2,000
Q1 2021 Apr 12, 2021	SELL	$60.0 - $68.46 $3,000 - $3,422	-50 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $2,832 - $3,227	50 New	50 $2,000
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $5,299 - $5,829	-86 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$62.51 - $69.0 $61,447 - $67,827	-983 Reduced 91.96%	86 $5,000
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $66,139 - $74,167	1,069 New	1,069 $72,000
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $33,236 - $43,371	-549 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $39,132 - $43,327	549 New	549 $42,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.